334 related articles for article (PubMed ID: 10169229)
21. Canada's laws on pharmaceutical intellectual property: the case for fundamental reform.
Grootendorst P; Bouchard R; Hollis A
CMAJ; 2012 Mar; 184(5):543-9. PubMed ID: 22065362
[No Abstract] [Full Text] [Related]
22. Realizing two-tiered innovation policy through drug regulation.
Ridgway WE
Stanford Law Rev; 2006 Feb; 58(4):1221-50. PubMed ID: 16685807
[No Abstract] [Full Text] [Related]
23. Applications for FDA approval to market a dew drug: patent submission and listing requirements and application of 30-month stays on approval of abbreviated new drug applications certifying that a patent claiming a drug is invalid or will not be infringed. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2003 Jun; 68(117):36675-712. PubMed ID: 12814136
[TBL] [Abstract][Full Text] [Related]
24. Legal challenge to India's patent laws threatens access to generic drugs, says charity.
Moszynski P
BMJ; 2011 Sep; 343():d5753. PubMed ID: 21908529
[No Abstract] [Full Text] [Related]
25. Canada ordered to implement WTO ruling against "stockpiling" of generic drugs.
Elliott R
Can HIV AIDS Policy Law Rev; 2000; 5(4):27. PubMed ID: 11833161
[TBL] [Abstract][Full Text] [Related]
26. Teva v. Eisai: what's the real "controversy"?
Wang GL
Food Drug Law J; 2011; 66(4):631-54, iii. PubMed ID: 24505831
[TBL] [Abstract][Full Text] [Related]
27. Branded drug reformulation: the next brand vs. generic antitrust battleground.
Amoresano GV
Food Drug Law J; 2007; 62(1):249-56. PubMed ID: 17444032
[No Abstract] [Full Text] [Related]
28. Changes to India's patent law may deny cheap drugs to millions.
Mudur G
BMJ; 2005 Mar; 330(7493):692. PubMed ID: 15790640
[No Abstract] [Full Text] [Related]
29. Intellectual property. Challenges to India's pharmaceutical patent laws.
Sampat BN; Shadlen KC; Amin TM
Science; 2012 Jul; 337(6093):414-5. PubMed ID: 22767892
[No Abstract] [Full Text] [Related]
30. TRIPS from Doha to Cancún ... to Ottawa: global developments in access to treatment and Canada's Bill C-56.
Elliott R
Can HIV AIDS Policy Law Rev; 2003 Dec; 8(3):1, 7-18. PubMed ID: 15104062
[TBL] [Abstract][Full Text] [Related]
31. Has the implementation of the TRIPS Agreement in Latin America and the Caribbean produced intellectual property legislation that favours public health?
Oliveira MA; Bermudez JA; Chaves GC; Velásquez G
Bull World Health Organ; 2004 Nov; 82(11):815-21. PubMed ID: 15640916
[TBL] [Abstract][Full Text] [Related]
32. Canada to change patent law to allow export of cheap drugs.
Kondro W
Lancet; 2003 Oct; 362(9392):1290. PubMed ID: 14577437
[No Abstract] [Full Text] [Related]
33. The effect of generic competition on the price of brand-name drugs.
Lexchin J
Health Policy; 2004 Apr; 68(1):47-54. PubMed ID: 15033552
[TBL] [Abstract][Full Text] [Related]
34. Sublicense or supply agreement? Supreme Court of Canada interpretation benefits generic pharmaceutical industry.
Burshtein S
Food Drug Law J; 1999; 54(1):73-91. PubMed ID: 11758562
[No Abstract] [Full Text] [Related]
35. Intellectual property. Fixing the legal framework for pharmaceutical research.
Knowles SM
Science; 2010 Feb; 327(5969):1083-4. PubMed ID: 20150445
[No Abstract] [Full Text] [Related]
36. Patent. Battle lines are drawn over generic AIDS drug.
AIDS Policy Law; 2005 Aug; 20(16):6. PubMed ID: 16161208
[No Abstract] [Full Text] [Related]
37. Reforming Canada's Access to Medicines Regime.
Elliott R
CMAJ; 2007 Jul; 177(3):270-1. PubMed ID: 17664453
[No Abstract] [Full Text] [Related]
38. A tragically naive Canadian law for tragically neglected global health.
Attaran A
CMAJ; 2007 Jun; 176(12):1726-7. PubMed ID: 17449707
[No Abstract] [Full Text] [Related]
39. FDA's proposed rules on patent listing requirements for new drug and 30-month stays on ANDA approval (proposed Oct. 24, 2002).
Hui YF
Ann Health Law; 2003; 12(2):325-40, table of contents. PubMed ID: 12856462
[TBL] [Abstract][Full Text] [Related]
40. Repercussions of the Drug Price Competition and Patent Term Restoration Act of 1984.
Hogan GF
Am J Hosp Pharm; 1985 Apr; 42(4):849-51. PubMed ID: 4014238
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
